Vitrafy Life Sciences Limited (ASX:VFY)
Australia · Delayed Price · Currency is AUD 3.810
+0.010 (0.26%)
Aug 26, 2026, 3:58 PM AEST
Vitrafy Life Sciences Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -16.17 | -32.71 | -10.43 | -7.81 | -7.66 |
Depreciation & Amortization | 0.12 | 0.15 | 0.21 | 0.26 | 0.19 |
Other Amortization | - | - | 2.03 | 0.81 | - |
Asset Writedown & Restructuring Costs | 0.17 | - | - | - | - |
Stock-Based Compensation | 0.53 | 2.08 | 0.19 | 0.36 | 0.11 |
Other Operating Activities | 0 | 18.9 | 1.78 | 0.65 | 3.03 |
Change in Accounts Receivable | -0.53 | -0.45 | -0.05 | -0.02 | -0.02 |
Change in Accounts Payable | 0.59 | 0.37 | -0.23 | 0.31 | -0.11 |
Change in Unearned Revenue | -1.43 | 1.43 | - | - | - |
Change in Other Net Operating Assets | 0.94 | 1.43 | -0.3 | 0.49 | -1.42 |
Operating Cash Flow | -15.77 | -8.8 | -6.79 | -4.96 | -5.87 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -0.54 | -0 | -0.01 | -0.09 | -0.49 |
Investment in Securities | -5 | -10.08 | - | - | - |
Investing Cash Flow | -5.54 | -10.08 | -0.01 | -0.09 | -0.49 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | - | - | 12.55 | 6.31 | - |
Total Debt Issued | - | - | 12.55 | 6.31 | - |
Short-Term Debt Repaid | - | - | -0.55 | -0.4 | - |
Long-Term Debt Repaid | -0.09 | -0.08 | -0.13 | -0.1 | -0.06 |
Total Debt Repaid | -0.09 | -0.08 | -0.68 | -0.5 | -0.06 |
Net Debt Issued (Repaid) | -0.09 | -0.08 | 11.87 | 5.82 | -0.06 |
Issuance of Common Stock | 30 | 35.32 | 0.27 | 0.09 | - |
Other Financing Activities | -2.03 | -3.25 | -0.64 | -0.1 | - |
Financing Cash Flow | 27.88 | 31.99 | 11.5 | 5.8 | -0.06 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | 0.01 | - | - | - | - |
Net Cash Flow | 6.58 | 13.11 | 4.69 | 0.76 | -6.42 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -16.31 | -8.8 | -6.8 | -5.05 | -6.36 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -7804.38% | -840.18% | -325.03% | -245.44% | -348.32% |
Free Cash Flow Per Share | -0.25 | -0.20 | -2.22 | -1.71 | -2.17 |
Levered Free Cash Flow | -10.84 | -18.33 | -9.08 | 0.73 | - |
Unlevered Free Cash Flow | -10.82 | -14.27 | -2.56 | 3.86 | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 0.02 | - | - | - | - |
Cash Income Tax Paid | -1.02 | -2.02 | - | - | - |
Change in Working Capital | -0.43 | 2.78 | -0.58 | 0.78 | -1.55 |